Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Dendritic Cell Sarcoma, Interdigitating × durvalumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 45 Lung Neoplasms 29 Carcinoma, Hepatocellular 20 Small Cell Lung Carcinoma 17 Urinary Bladder Neoplasms 12 Liver Neoplasms 10 Biliary Tract Neoplasms 10 Breast Neoplasms 8 Neoplasms 7 Stomach Neoplasms 5 Neoplasm Metastasis 5 Colorectal Neoplasms 5 Cholangiocarcinoma 5 Carcinoma, Transitional Cell 5 Triple Negative Breast Neoplasms 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Non-Muscle Invasive Bladder Neoplasms 4 Carcinoma 4 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms by Site 3 Endometrial Neoplasms 3 Adenocarcinoma Of Esophagus 3 Adenocarcinoma 3 Thoracic Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Pathologic Complete Response 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2

Interventions

glofitamab 2 zanubrutinib 1 venetoclax 1 pirtobrutinib 1 pembrolizumab 1 obinutuzumab 1 Rituximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡